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Erythropoietin receptor-operated Ca21 channels: Activation by phos-
pholipase C-g1. Erythropoietin (EPO) increases Ca21 influx in vascular
smooth muscle cells and acts both as a direct vasoconstrictor and vascular
growth factor (that is, angiogenesis). However, the mechanism by which
EPO promotes extracellular Ca21 entry in contractile cells has not been
elucidated. In hematopoietic cells, EPO induces tyrosine kinase (TK)-
dependent activation of phospholipase C (PLC)-g1 and Ca21 influx via a
voltage-independent Ca21 conductance. In contractile mesangial cells, we
have recently characterized a voltage-independent, 1 pS Ca21 channel that
is dependent on both TK and PLC-g1 activity. Therefore, we examined
cultured rat glomerular mesangial cells after timed exposure to recombi-
nant human EPO (20 U/ml). Erythropoietin increased the tyrosine
phosphorylation of PLC-g1, promoted membrane complex formation
between PLC-g1 and the EPO receptor itself, and raised the levels of
intracellular inositol 1,4,5-trisphosphate and intracellular Ca21. Consis-
tent with our previous studies, 1 pS Ca21 channel activity was extremely
low under basal, unstimulated conditions in cell-attached patches, but was
dramatically increased when EPO was present in the patch pipette.
Tyrosine kinase inhibition with 100 mM genistein or 1 mM PP1 (Src;
selective tyrosine kinase inhibitor) prevented all of these EPO-induced
responses. We conclude that: (1) EPO-induced stimulation of 1 pS Ca21
channels is mediated via a cytosolic Src TK in glomerular mesangial cells.
(2) Stimulation of this Ca21-activated, Ca21-permeable channel is depen-
dent on the tyrosine phosphorylation/activation of PLC-g1. (3) This
cascade provides a possible mechanism for the vasoconstriction and
hypertension observed with clinical EPO use for the treatment of chronic
anemias.
Human recombinant erythropoietin (EPO) therapy for the
treatment of chronic anemias is associated with an increased
incidence of new onset hypertension and a worsening of pre-
existing hypertension [1–5]. Erythropoietin acts as both a direct
vasoconstrictor and a vascular growth factor (that is, angiogene-
sis) [2, 5–7]. In platelets from hypertensive patients and hyperten-
sive rat models, but not in platelets from normotensive patients or
rats, EPO elevates cytosolic Ca21 levels [8, 9]. Similarly, EPO
increases intracellular Ca21 concentrations in vascular smooth
muscle cells [1]. However, the mechanism by which EPO mediates
increases in intracellular Ca21 levels in contractile cells has not
been elucidated.
In hematopoietic cells, EPO induces tyrosine kinase-dependent
activation of phospholipase C (PLC)-g1 and extracellular Ca21
influx via a voltage-independent, EPO receptor-operated Ca21
conductance pathway [8, 10–15]. The g isoforms of PLC are
classically activated after tyrosine phosphorylation by growth
factor receptor-linked tyrosine kinase activity [such as platelet-
derived growth factor (PDGF), epidermal growth factor, fibro-
blast growth factor]. However, unlike classic growth factor recep-
tors, EPO and other similar cytokine receptors do not possess
intrinsic tyrosine kinase activity [16]. Despite this fact, EPO has
been shown to stimulate rapid protein tyrosine phosphorylation in
hematopoietic cells [11, 16–21]. Cytosolic protein tyrosine ki-
nases, which are activated by receptors lacking intrinsic kinase
activity (such as interleukins, interferons, angiotensin II), include
members of the Src family (such as p60src, p59fyn, p56lck, p62yes)
[22]. We have shown that p60src indeed does promote the tyrosine
phosphorylation and activation of PLC-g1, leading to the hydro-
lysis of phosphatidylinositol 4,5-bisphosphate (PIP2) and the
generation of inositol 1,4,5-trisphosphate (IP3) [23–25]. This
PLC-g1 cascade stimulates a biphasic rise in intracellular Ca21
consisting of an initial release from IP3-sensitive intracellular
Ca21 stores followed by an influx of extracellular Ca21. In
non-excitable tissues, including glomerular mesangial and vascu-
lar smooth muscle cells, the influx of extracellular Ca21 is an
important prerequisite for contraction and the initiation of cellu-
lar DNA synthesis and proliferation [26, 27]. Evidence suggests
that this extracellular Ca21 influx occurs via voltage-independent,
receptor-operated Ca21 channels [28–30].
In glomerular mesangial cells and vascular smooth muscle cells,
we have recently identified PLC-g1 and have shown that PLC-g1
is tyrosine phosphorylated and activated by both receptors pos-
sessing (for example, PDGF-b receptor) and lacking (such as
angiotensin II receptor) intrinsic tyrosine kinase activity [23–25,
29]. Our group has also characterized a voltage-independent,
receptor-operated Ca21 channel in rat glomerular mesangial cells
[27–29, 31]. There are approximately 1000 of these low conduc-
tance (1 pS) Ca21-permeable channels channels per cell (or 4 3
107 channels/cm2). The channels are inactive under basal condi-
tions; they are strongly activated by growth factors (such as
PDGF); and, to be active, they require activation of at least one
tyrosine kinase and activation of PLC-g1. All of these features
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make this 1 pS Ca21 channel a potential candidate for mediating
the previously reported voltage-independent, EPO receptor-op-
erated Ca21 entry [8, 11–15]. In the present study, we investigated
the role of tyrosine kinases, PLC-g1 tyrosine phosphorylation,
PLC-g1/EPO receptor complex formation, and intracellular Ca21
in the regulation of the 1 pS Ca21 channel by EPO in cultured rat
glomerular mesangial cells.
METHODS
Preparation of rat glomerular mesangial cell cultures
Glomerular mesangial cells were cultured using previously
described methods [24, 28, 31–33]. Briefly, renal cortices were
dissected from male Sprague-Dawley rats (75 to 150 g). Mesangial
cell-enriched glomerular cores were isolated by differential siev-
ing and incubated for 45 to 60 minutes with collagenase (1200
U/ml) in Ca21/Mg21 free Hank’s balanced salt solution (Irvine
Scientific, Santa Ana, CA, USA). The mesangial cell suspension
was washed and plated in standard RPMI-1640 medium supple-
mented with 17% (vol/vol) fetal bovine serum, 2 mM glutamine, 5
mg/ml insulin, 5 mg/ml transferrin, 5 ng/ml selenium, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 2 mg/ml amphotericin B at
37°C in 5% CO2/95% air. For immunoblot analysis and measure-
ment of intracellular IP3 levels, mesangial cell subpassages 3 to 5
were grown to near confluence in 100 mm culture dishes (Fisher
Scientific, Pittsburgh, PA, USA). To growth arrest the cells,
medium was replaced with serum-free medium for 24 to 48 hours
prior to each experiment. For patch clamp experiments, mesangial
cell subpassages 3 to 5 were grown to confluency on glass
coverslips.
Immunoprecipitation of phospholipase C-g1 in mesangial cell
lysates
Mesangial cells, grown in 100 mm dishes to near confluence,
were growth-arrested in 5 ml of serum-free RPMI-1640 for 24 to
48 hours. Cultures were then exposed to EPO for timed periods.
Incubations were terminated by aspirating the medium and
washing two to three times in ice-cold PBSV (phosphate-buffered
saline with 1 mM Na3VO4). Each dish was then treated with 2 ml
of ice-cold lysis buffer (25 mM Tris-HCl, pH 7.4, 1% Triton X-100,
10% glycerol, 10 mM Na3P2O7, 50 mM NaF, 1 mM Na3VO4, 1 mM
PMSF and 10 mg/ml aprotonin) and placed on ice for 30 minutes.
The thawed cells were harvested by scraping and sonicated for five
seconds. with a Cole Parmer ultrasonic homogenizer, and then the
homogenate was centrifuged at 6,000 3 g for 20 minutes. The
soluble extracts were precleared with 20 to 30 ml/ml cell lysate of
Immunoprecipitin (Life Technologies, Inc., Grand Island, NY,
USA), which are membranes of formalin-fixed, heat-killed Staph-
ylococcus aureus bacteria. To immunoprecipitate phosphotyrosine
proteins from the cleared lysate, we used 5 mg/ml antiphosphoty-
rosine (PY20) monoclonal antibody (Transduction Laboratories,
Lexington, KY, USA). To immunoprecipitate PLC-g1 directly, we
used 5 mg/ml of a mixed monoclonal anti-PLC-g1 antibody
(Upstate Biotechnology Inc., Lake Placid, NY, USA) as previ-
ously described [24]. The immunoprecipitates were then recov-
ered by centrifugation and washed four times with ice-cold wash
buffer (25 mM Tris-HCl, pH 7.4, 0.1% Triton X-100, 150 mM
NaCl, and 2 mM Na3V04). Immunoprecipitated proteins were
dissolved in 80 ml of Laemmli buffer, boiled for five minutes at
95°C, and analyzed on 10% gels by SDS-PAGE. Proteins were
then transferred to nitrocellulose membranes for 16 hours at 100
mA. The membrane was blotted with either anti-PLC-g1 mono-
clonal antibody or antiphosphotyrosine (4G10) monoclonal anti-
body (Upstate Biotechnology). The proteins were detected using
Enhanced Chemiluminescense (Amersham Corp., Arlington
Heights, IL, USA).
Immunoprecipitation of EPO receptor/PLC-g1 complex in
mesangial cell membrane fractions
Mesangial cells, grown to near confluence, were growth-ar-
rested in 5 ml of serum-free RPMI-1640 for 24 hours and then
exposed to EPO. To terminate the incubation, the cells were
washed three times with ice cold PBS plus 1 mM Na3V04.
Hypotonic buffer (50 mM Tris-HCl, pH 7.4, 2 mM Na3VO4, 50 mM
NaF, 10 mM Na2P2O7, 1 mM phenylmethylsulfonyl fluoride, 10
mg/ml leupeptin, 10 mg/ml aprotinin) was added and the cells were
then placed on ice to thaw for 30 minutes. The thawed cells were
scraped from the plate and centrifuged for 20 minutes at 6,000 3
g at 4°C. The supernatant was discarded and to the pellet was
added 1 ml of ice-cold lysis buffer, followed by incubation for one
hour at 4°C. After centrifugation for 20 minutes at 6,000 3 g at
4°C, the supernatant was collected, anti-EPO receptor antibody (5
ml/ml lysate) was added, followed by incubation overnight at 4°C.
The next day, Protein A/G plus 30 ml of buffer (2 mM Na3VO4, 50
mM NaF, 10 mM Na2P2O7, 1 mM phenylmethylsulfonyl fluoride, 10
mg/ml leupeptin, 10 mg/ml aprotinin) was added while rocking at
4°C for two to three hours. The immunoprecipitates were then
recovered by centrifugation and washed three times with ice-cold
wash buffer (50 mM Tris-HCl, pH 7.4, 0.1% NP-40, 150 mM NaCl,
1 mM Na3VO4). Immunoprecipitated membrane proteins were
dissolved in 80 ml of Laemmli buffer, boiled for five minutes at
95°C, and analyzed on 10% gels by SDS-PAGE. Proteins were
then transferred to nitrocellulose membranes and blotted with
anti-PLC-g1 antibody. The proteins were detected using en-
hanced chemiluminescense.
Measurement of inositol 1,4,5-trisphosphate
Following mesangial cell exposure to 20 U/ml EPO, the incu-
bation was stopped by the addition of 1 ml of 100% ice-cold
trichloroacetic acid to the plates. The plates were placed on ice for
10 minutes. The cells were then harvested by scraping and
transferring to polyethylene tubes. The cell extract was sonicated
on ice with a Cole Parmer ultrasonic homogenizer for approxi-
mately one minute and then centrifuged for 10 minutes at 6,000 3
g. The supernatant was removed and warmed to room tempera-
ture for 15 minutes. Levels of IP3 in each supernatant were
determined using a radioimmunoassay based kit (Dupont NEN,
Boston, MA, USA) as previously described [24, 29].
Confocal intracellular Ca21 fluorescent imaging
To measure intracellular Ca21 levels, fluorescence was mea-
sured with mesangial cells grown on glass cover slips [34]. Cells
were preincubated with 5 mM Indo-1 AM (Molecular Probes,
Eugene, OR, USA) for 30 minutes at room temperature in
darkness and then washed with saline solution three times. Cover
slips were then placed in a chamber secured to the stage of a
Meridian ACAS 570/Ultima laser scanning confocal microscope
(Laser Cytofluorimeter Working Station; Meridian Instruments,
MI, USA). Cells loaded with Indo-1 AM were excited by UV light
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at 351 to 364 nm and the cytoplasmic free calcium signal was read
as the fluorescence ratio at 405 nm and 530 nm wave lengths.
Intracellular Ca21 concentrations were calculated by using the
standard working curves of fluorescence ratio versus free Ca21 in
Ca21-EGTA buffer.
Patch-clamp recording
TW150F-6 glass pipettes (World Precision Instruments, New
Haven, CT, USA) were prepared with a PP-83 patch-pipette
puller and a MF-83 pipette polisher (Narishige, Tokyo, Japan)
[31–33]. Pipettes with resistances of . 10 megaohms were used
for the experiments. Single-channel patch clamp configurations,
including the cell-attached and inside-out modes, were established
on the membrane of mesangial cells cultured on glass coverslips.
In the cell-attached mode, single channel currents were recorded
without applying potential to the pipette (that is, resting mem-
brane potential). In the excised inside-out mode, single channel
recordings were obtained with 160 mV applied pipette voltage
(Vm 5 260 mV). All experiments were conducted with an
Axopatch-1D amplifier (Axon Instruments, Foster, CA, USA) at
room temperature, 22 to 23°C. Only patches with a seal resis-
tance . 30 gigaohms and containing currents without baseline
drift were used for experiments. Data were digitally recorded with
a DAS 601 Pulse Code Modulator (Dagan Corp., MN, USA) and
a SL-HF860D VCR (Sony Corp. of America, NJ, USA), and
acquired using a 902LPF 8-pole Bessel filter (Frequency Devices
Inc., MA, USA), TL-2 acquisition hardware and Axotape software
(Axon Instruments). Single channel traces were sampled at 2
msec/point and software filtered at 100 Hz, and inward Ca21 or
Mn21 current (pipette to cell) was represented by downward
channel transitions. Single channel analysis was performed on
IBM PC class computers using both Pclamp 6.0 and locally-
developed software [31–33]. NPo (number of channels times the
open probability) was used as a measure of channel activity. All
NPo values were calculated from three minutes of single channel
recording and are reported as mean values 6 SEM. When cell-
attached patch experiments were conducted in a paired fashion
(that is, data from each patch membrane serving as the control for
an experimental manipulation), the average change in NPo for a
group of patches, compared before and after an experimental
treatment, was analyzed using a paired t-test or analysis of
variance (ANOVA) for multiple comparisons. For unpaired ex-
periments, the traditional t-test or ANOVA was used. Results
were considered significant if P , 0.05. Statistical analysis was
performed with SigmaPlot and SigmaStat software (Jandel Scien-
tific, CA, USA).
Solutions and chemicals
For cell-attached patch experiments, the standard extracellular
bath solution (outside the patch pipette) contained (in mM) 140
NaCl (after adjusting pH to 7.4 with NaOH), 4 KCl, 1 CaCl2, 1
MgCl2 and 10 HEPES. When excised inside-out patch experi-
ments were performed, the “cytoplasmic” bath solution contained
(in mM) 140 KCl (after adjusting pH to 7.4 with KOH), 10 NaCl,
1 MgCl2, 2 EGTA and 10 HEPES. The “cytoplasmic” bath CaCl2
was varied for different experiments and was reported as the final
free Ca21 activity. Since we were primarily interested in the
function of the specific EPO- (and PDGF-) activated calcium
channel and since the unit conductance of this channel was quite
low conductance, we used a solution in the patch pipette which
was high in calcium to the exclusion of other cations similar to the
solution that had allowed us to first identify the channel [31]. The
solution contained (in mM) 110 CaCl2, 4 KCl (after adjusting pH
to 7.4 with KOH), 1 MgCl2, and 10 HEPES. Tween 20, acryl-
amide, N-N9-methylene-bisacrylamide, N,N,N9,N9-tetramethyl-
enediamine, and SDS were purchased from Bio-Rad Labs (Her-
cules, CA, USA). Prestained molecular weight standards,
genistein, and Immunoprecipitin were obtained from Life Tech-
nologies, Inc. (Grand Island, NY, USA). Penicillin, streptomycin,
insulin, PP1 and Indo-1 were purchased from Calbiochem Corp.
(San Diego, CA, USA) and Sigma Chemical Corp. (St. Louis,
MO, USA). Human recombinant erythropoietin was obtained
from Amgen (Thousand Oaks, CA, USA). Nitrocellulose mem-
branes and sheep anti-mouse IgG were purchased from Amer-
sham Corp. Monoclonal antibodies to PLC-g1 and antiphospho-
tyrosine (4G10) were obtained form Upstate Biotechnology, Inc.
Goat anti-mouse IgG was obtained from Jackson ImmunoRe-
search Laboratories, Inc. (West Grove, PA, USA). Antiphospho-
tyrosine (PY20) and EPO receptor antibodies were obtained from
Transduction Laboratories and protein A/G plus agarose came
from Santa Cruz Biotechnologies, Inc. (Santa Cruz, CA, USA).
RESULTS
Effect of erythropoietin on phospholipase C-g1 in glomerular
mesangial cells
Ren et al [10] have shown that EPO stimulates the tyrosine
phosphorylation and activation of PLC-g1 in a hematopoietic cell
line. In glomerular mesangial and vascular smooth muscle cells,
we have previously shown that classic growth factors, such as
PDGF, promote the tyrosine phosphorylation and activation of
PLC-g1 [25, 27, 28, 31]. However, we have also shown that
PLC-g1 can be activated by receptors that, like the EPO receptor,
lack intrinsic tyrosine kinase activity, but rather operate via
cytosolic tyrosine kinases (such as angiotensin II) [23–25, 35].
Therefore, we examined EPO-induced tyrosine phosphoryla-
tion of PLC-g1 in cultured rat glomerular mesangial cells by
immunoprecipitation. Tyrosine phosphorylated proteins were first
immunoprecipitated using antiphosphotyrosine antibodies and
then probed with anti-PLC-g1 antibodies. When compared to
basal levels, exposure to 20 U/ml EPO produced an increase in the
tyrosine phosphorylation of PLC-g1 within 30 seconds (N 5 3;
Fig. 1). Peak phosphorylation was observed within five minutes of
EPO exposure and then returned to baseline by 30 minutes. We
also performed the experiment reversing the order of antibody
addition, first immunoprecipitating mesangial cell lysates with
anti-PLC-g1 antibodies and then probing with antiphosphoty-
rosine antibody. Again, a significant increase in the tyrosine
phosphorylation of PLC-g1 was observed upon exposure to 20
U/ml EPO (N 5 3; data not shown). The peak phosphorylation
response was again observed within five minutes. of EPO expo-
sure. In mesangial cells which were first preincubated with
tyrosine kinase inhibitors, 100 mM genistein for one hour (N 5 3)
or 1 mM PP1 for 15 minutes (N 5 3), the usual EPO-induced
tyrosine phosphorylation of PLC-g1 was abolished (Fig. 1).
Membrane complex formation between phospholipase C-g1 and
the erythropoietin receptor
We and other groups have previously shown that growth
factor-mediated tyrosine phosphorylation of PLC-g1 promotes
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the formation of a membrane-bound complex between PLC-g1
and the growth factor receptors themselves (such as PDGF-b
receptor/PLC-g1 complex) [27, 28, 31, 36, 37]. Therefore, we
investigated the ability of EPO to promote the membrane asso-
ciation of PLC-g1 with the EPO receptor itself in glomerular
mesangial cells. Mesangial cells were incubated in EPO (20 U/ml)
for various time periods followed by isolation of the membrane
fractions. We first immunoprecipitated the isolated membrane
fraction with an anti-EPO receptor antibody. Probing the immu-
noprecipitated proteins with an anti-PLC-g1 antibody revealed
the formation of a membrane-associated PLC-g1/EPO receptor
complex (N 5 3; Fig. 2). Membrane fractions were also examined
from mesangial cells preincubated with either 100 mM genistein
for one hour (N 5 3) or 1 mM PP1 for 15 minutes (N 5 3) prior
to timed exposures to EPO. Proteins were again immunoprecipi-
tated with anti-EPO receptor antibodies and then probed with
anti-PLC-g1 antibodies. Under these conditions, the 145 kDa
band (molecular weight of PLC-g1) was no longer observed, as
shown in Figure 2 for cells that were preincubated with PP1.
These studies suggested that tyrosine kinase activity, perhaps
involving cytosolic Src kinases, was essential for EPO-induced
membrane recruitment of PLC-g1 and for membrane complex
formation between PLC-g1 and the EPO receptor itself in
glomerular mesangial cells.
Effect of erythropoietin on 1 pS Ca21 channels in glomerular
mesangial cells
In glomerular mesangial cells, we have previously shown that
PLC-g1 tyrosine phosphorylation and PLC-g1/growth factor re-
ceptor complex formation promotes the activation of receptor-
operated, 1 pS Ca21 channels [27, 28, 31]. Erythropoietin induces
tyrosine kinase-dependent extracellular Ca21 influx via a voltage-
independent, EPO receptor-operated Ca21 conductance pathway
in hematopoietic cells [8, 11–15]. However, this voltage-indepen-
dent, EPO receptor-operated Ca21 conductance has not been
characterized at a single channel level. Therefore, we investigated
the effect of EPO on the 1 pS Ca21 channel in cultured rat
glomerular mesangial cells. Consistent with our previous studies,
1 pS Ca21 channel activity was extremely low under basal,
unstimulated conditions in cell-attached patches; NPo (number of
channels times the open probability) was 0.06 6 0.02 (N 5 8; Fig.
3). The addition of recombinant human EPO (20 U/ml) to the
extracellular bath outside the cell-attached patch pipette did not
increase channel activity recorded from the cell-attached mem-
brane patch (NPo 5 0.09 6 0.04; N 5 7) from basal values (P 5
0.55). In contrast, channel activity was dramatically increased
when recombinant human EPO (20 U/ml) was present inside the
patch pipette; NPo was 0.73 6 0.09 (N 5 10). Intrapipette EPO
significantly increased channel activity over basal values (P ,
0.00002). We also examined the time course of EPO’s activation
of channels. We presumed that the formation of the seal resulted
in a step change in EPO concentration and calculated the open
probability for three second windows starting from the time of
seal formation. Three such records of open probability were
averaged to produce the mean open probability shown in the
lower left panel of Figure 3. These results demonstrate that the
time course of activation is consistent with the time course of PLC
Fig. 1. Erythropoietin (EPO)-induced tyrosine phosphorylation of phospholipase C (PLC)-g1. (Western blot, inset) Mesangial cells exposed to 20
U/ml EPO for various timed periods. Mesangial cell lysates were then immunoprecipitated with antiphosphotyrosine antibody (PY-20) and probed with
anti-PLC-g1 antibody. The PLC-g1 bands were quantitated by densitometry using a La Cie scanner interfaced with a personal computer. Each band
was scanned in two dimensions and the density corrected for the background present in the lane. The results shown in the graph represent the corrected
density for each time point and are expressed as arbitrary units plotted against time of EPO exposure in mesangial cells that were either pre-treated
with tyrosine kinase inhibitors, 100 mM genistein () for one hour or 1 mM PP1 (F) for 15 minutes, or vehicle (E). Each data point represents mean 6
SE for N 5 3 separate plates of mesangial cells.
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phosphorylation. However, since channel opening is a stochastic
process, a precise determination of the time course would require
summing of many more records. Thus, we feel that, while the time
course of channel activation is similar to that of PLC phosphor-
ylation, the channel activation time should be interpreted with
caution.
We then investigated the effect of tyrosine kinase inhibition on
EPO-induced 1 pS Ca21 channel activation. Channel activity was
first recorded with cell-attached patch pipettes containing 20 U/ml
EPO (Fig. 4). Genistein (100 mM) was then added to the extra-
cellular bath outside the patch pipette [24, 28, 29]. Despite the
continued presence of intrapipette EPO, tyrosine kinase inhibi-
tion abolished Ca21 channel activity, decreasing NPo from 0.56 6
0.14 to 0.08 6 0.02 (P , 0.01; N 5 8). Another set of mesangial
cells were pretreated with PP1 (1 mM), an inhibitor [38], for 15
minutes prior to patching. Basal Ca21 channel NPo after PP1
pretreatment was 0.04 6 0.01 (N 5 7; Fig. 4). NPo under the latter
condition was not significantly different from basal Ca21 channel
activity recorded in the absence of PP1 (Fig. 3). However, PP1
prevented the usual channel activation observed when EPO was
present in the cell-attached patch pipette (NPo 0.06 6 0.03; N 5
7; P 5 0.60; Fig. 4). These results suggested that EPO-induced
activation of the 1 pS Ca21 channel was dependent on protein
tyrosine phosphorylation likely involving a member of the Src
family of cytosolic tyrosine kinases.
Role of intracellular Ca21 in 1 pS Ca21 channel activation by
erythropoietin
Pholipase C promotes the release of Ca21 from IP3-dependent
intracellular stores, which in turn triggers voltage-independent
Ca21 entry in multiple cell types, including glomerular mesangial
cells [24, 25, 29, 30]. In hematopoietic and vascular cell types,
EPO elevates cytosolic Ca21 levels [1, 8, 9, 11–15]. Therefore, we
measured intracellular IP3 levels in glomerular mesangial cells
(Fig. 5) and found that exposure to 20 U/ml EPO significantly
increased IP3 levels with a time course paralleling EPO-induced
tyrosine phosphorylation of PLC-g1 and membrane complex
formation between PLC-g1 and the EPO receptor. Using confocal
microscopy, we also measured intracellular Ca21 levels in Indo-
1-loaded glomerular mesangial cells. In response to 20 U/ml EPO
exposure, intracellular Ca21 levels did indeed increase from basal
values (Fig. 6). The peak intracellular Ca21 response occurred
approximately 20 minutes after EPO exposure. Erythropoietin-
induced increases in intracellular IP3 and Ca
21 levels were
markedly attenuated by pretreatment with 100 mM genistein (1 hr)
or 1 mM PP1 (15 min).
Other groups have shown that intracellular Ca21 release plays
an important role in the regulation of receptor-operated Ca21
entry in many non-excitable cell types [30]. In particular, we have
shown that growth factor-induced increases in intracellular Ca21
leads to activation of the 1 pS Ca21 channel in glomerular
mesangial cells, and that in the absence of intracellular Ca21 the
channels were completely inactive [29]. Therefore, we examined
the role of intracellular Ca21 on 1 pS channel activity in cell-
attached patches. Without EPO present in the pipettes, cell-
attached patches were established and excised, exposing the
inside-out patch membranes to a “cytoplasmic” bath containing
1028 M Ca21; NPo was 0.007 6 0.012 (N 5 5). Channel activity
increased significantly when “cytoplasmic” bath Ca21 was raised
to 1027 M (NPo 5 0.25 6 0.08; P , 0.01) and then to 10
26 M (NPo
Fig. 2. Erythropoietin (EPO)-induced membrane complex formation between phospholipase C (PLC)-g1 and the EPO receptor. Mesangial cells were
treated for the times indicated with 20 U/ml EPO in cells that were or were not pre-treated with PP1 (1 mM) for 15 minutes prior to the addition of
the EPO. The membrane fraction was then separated after hypotonic cellular lysis. Proteins were first immunoprecipitated with an anti-EPO receptor
antibody and developed with an anti-PLC-g1 antibody. A representative experiment shows a significant increase in EPO/PLC-g1 complex formation
within 30 seconds of EPO exposure.
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5 0.65 6 0.10; P , 0.02). Combined with our biochemical results,
these findings suggested that EPO-induced activation of 1 pS
Ca21 channels occurs via the tyrosine phosphorylation and acti-
vation of PLC-g1 leading to the localized release of IP3-depen-
dent intracellular Ca21 stores.
DISCUSSION
Erythropoietin-induced 1 pS Ca21 channel activation is
dependent on Src-specific tyrosine kinases
Erythropoietin has been shown to stimulate voltage-indepen-
dent Ca21 influx in multiple cell types, including vascular smooth
muscle and hematopoietic cells [8, 11–15]. Our previous patch
clamp studies have characterized voltage-independent, PDGF-b
receptor-operated 1 pS Ca21 channels in glomerular mesangial
cells [27–29, 31]. In our present study, we find that EPO also
activates the same 1 pS Ca21 channel in cell-attached patches on
cultured rat glomerular mesangial cells. Channel activation by
EPO is significantly reduced by two structurally different tyrosine
kinase inhibitors: genistein and PP1. We have previously shown
that tyrosine kinase inhibition (such as with genistein and trypho-
stin 9) blocks the activation of 1 pS Ca21 channels by PDGF in
glomerular mesangial cells [28, 29]. Genistein has also been shown
to block receptor-operated Ca21 influx in rat pancreatic acinar
cells, human fibroblasts, and mouse osteoblast-like cells [28].
While genistein is a nonspecific tyrosine kinase inhibitor that
competes for the ATP binding site, PP1 is a Src-specific tyrosine
kinase inhibitor [38]. Cytokine receptors related to the EPO
receptor (such as interleukin, interferon) lack intrinsic receptor
tyrosine kinase activity, but have been shown to activate cytosolic
Src tyrosine kinases in multiple cell types [16, 24, 28].
Erythropoietin promotes tyrosine phosphorylation and
activation of phospholipase C-g1 in mesangial cells
In multiple cell types, a number of proteins are tyrosine
phosphorylated in response to EPO. These tyrosine phosphory-
lated proteins include phospholipase C-g1, the EPO receptor
itself, DNA binding proteins (p84, p91, p93), phosphatidylinositol
3 kinase (PI3K), p120 GTPase-activating protein (GAP), p52shc,
Fig. 3. Erythropoietin (EPO)-induced 1 pS Ca21 channel activity. (Left) Representative traces depict 1 pS Ca21 channel activity in cell-attached
patches on glomerular mesangial cells. Channel activity was measured in the absence of EPO (Control), in the presence of 20 U/ml in the extracellular
bath outside the patch pipette, and in the presence of 20 U/ml inside the patch pipette. Inward current is represented by downward deflections. “C”
marks the zero current level (closed state) and O1 marks channel openings. (Lower left) The time course of EPO’s activation of channels. We presumed
that the formation of the seal resulted in a step change in EPO concentration and calculated the open probability for three seconds windows starting
from the time of seal formation. Three such records of open probability were averaged to produce the mean open probability. These results demonstrate
that despite the significant variability in the open probability (as expected for any single channel recording), the time course of activation is consistent
with the time course of PLC phosphorylation. (Right) Summary plot of NPo for all cell-attached patch experiments.
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STAT (signal transducers and activators of transcription) 1 and 5,
and several as yet unidentified proteins ranging in molecular
weight from 25 to 145 kDa [7, 10, 16–21, 39, 40].
Phospholipase C-g1 contains four tyrosine residue sites for
phosphorylation [24]. In glomerular mesangial cells, our biochem-
ical data show that EPO binding to its respective EPO receptor
leads to the tyrosine phosphorylation of PLC-g1. This in turn
promotes the formation of a membrane-associated complex be-
tween PLC-g1 and the EPO receptor itself. We find that EPO-
induced tyrosine phosphorylation of PLC-g1, PLC-g1/EPO recep-
tor membrane complex formation, and increases in intracellular
Ca21 are abolished by the tyrosine kinase inhibitors, genistein and
PP1.
Phospholipase C-mediated increases in intracellular IP3 levels
promotes the mobilization of intracellular Ca21 stores [24, 29]. In
mesangial cells, intracellular Ca21 concentrations are 1027 M
under basal conditions and increase to 1026 M in response to
IP3-mediated signal transduction pathways [29] [24]. Mene and
associates [30] have recently shown that the release of intracellu-
lar Ca21 stores or ionophore-mediated Ca21 entry promotes
voltage-independent Ca21 (or Mn21) entry in human glomerular
mesangial cells. They hypothesized that “the InsP3-sensitive Ca
21
pool may serve as a trigger for a sustained response, thus initiating
a cascade amplification signaling mechanism.” In the absence of
intrapipette EPO, we do indeed find that the 1 pS Ca21 channel
is itself directly activated by increasing “cytoplasmic” Ca21 con-
centrations (1028 to 1026 M) in excised inside-out patches. Our
results suggest that the Ca21 channels are initially triggered by
intracellular Ca21, released from IP3-dependent stores. Sustained
channel activation may be maintained by Ca21 entry through the
channel itself. Ca21-permeable channels allow Ca21 entry at
rates . 106 ions/sec [41]. Local Ca21 in the immediate vicinity of
the channel pore can reach high concentrations [41, 42], providing
a positive feedback loop for the Ca21-activated, 1 pS Ca21
channel.
Finally, we find that 1 pS Ca21 channel activity in excised
patches, at a given “cytoplasmic” Ca21 concentration, is higher
with intrapipette EPO present than without intrapipette EPO
Fig. 4. Effect of tyrosine kinase inhibition on erythropoietin (EPO)-induced Ca21 channel activity. (Upper left) Channel activity induced by
intrapipette EPO (20 U/ml) was recorded in cell-attached patches (upper trace). Within five minutes of adding 100 mM genistein to the extracellular
bath, channel activity was significantly inhibited (lower trace). (Lower left) Cell-attached patches were established on mesangial cells after 15 minutes
pretreatment with 1 mM PP1. Channel activity was measured in the absence (upper trace) and presence of intrapipette EPO (20 U/ml) (lower trace).
(Right) Summary plot of NPo for all cell-attached patch experiments. Symbols connected by lines represent the change in channel activity for the same
cell-attached patch before and after exposure to genistein.
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present (data not shown). This is consistent with the activation of
EPO receptor-operated Ca21 channels by another signal trans-
duction pathway besides PLC-g1. In mesangial cells, we have
recently shown that in addition to the PLC-g1 cascade, PDGF
stimulates the 1 pS Ca21 channel via the GRB-2 (growth factor
receptor binding protein 2)/SOS (son of sevenless)/Ras pathway.
Interestingly, several groups have shown that EPO can also
stimulate GRB-2 and the Ras pathway [19, 40]. These results
suggest that convergent signaling pathways are responsible for
EPO receptor-operated Ca21 influx and involve cytosolic Src
tyrosine kinases, the PLC-g1 cascade, and perhaps Ras oncogenes.
Pathological and physiological significance of the
erythropoietin-induced Ca21 channel
The administration of recombinant human EPO has become an
important clinical therapeutic adjunct to the treatment of patients
with chronic anemias (such as renal failure, myelodysplasia,
chemotherapy). However, the bone marrow is not the only EPO
target tissue and as a result, EPO administration has been
associated with complications that are independent of its hema-
tologic effects, most notably an increased incidence of hyperten-
sion [1–5]. Our present study suggests that a potential mechanism
for clinically observed EPO-induced vasoconstriction involves
extracellular Ca21 influx via EPO receptor-operated, 1 pS Ca21
channels. However, other mechanisms may be involved in EPO-
induced hypertension.
Erythropoietin is a well-characterized cytokine growth factor
responsible for the proliferation of erythroid progenitor cells [7,
10, 16–21, 39, 40]. Therefore, it is perhaps not surprising that in
addition to being a direct vasoconstrictor, EPO has been shown to
act as a vascular growth factor mediating the proliferation of
endothelial cells and aortic rings [6, 7]. In the present study, we
have shown that EPO stimulates Src tyrosine kinase, PLC-g1 and
1 pS Ca21 channel activity in glomerular mesangial cells, which
are phenotypically similar to vascular smooth muscle cells. Pre-
dictably, we have found that EPO also stimulates the tyrosine
phosphorylation of PLC-g1 and PLC-g1/EPO receptor complex
formation in rat aortic vascular smooth muscle cells (unpublished
data). The importance of tyrosine kinases, including the cytosolic
Src family, and PLC-g1 in controlling cellular growth and differ-
entiation is now well established [35]. DNA synthesis and PLC
activity is blocked by tyrosine kinase inhibition (genistein or
herbimycin A) and stimulated by tyrosine phosphatase inhibition
(vanadate) in human glomerular mesangial cells [26, 27]. In
fibroblasts, microinjection of PLC-g1 or PLC-g1 antibodies has
been shown to induce or inhibit DNA synthesis, respectively [26,
27]. Higher levels of PLC-g are found in cancer cells and may play
a role in abnormal cellular proliferation and mitogenesis [26, 27].
The initiation of cellular DNA synthesis and proliferation re-
quires the influx of extracellular Ca21 [26, 27]. Conversely,
inhibition of Ca21 entry blocks mitogenic responses [26, 27].
Finally, EPO activates multiple mitogenic signaling pathways in
addition to PLC (such as Ras/mitogen-activated protein kinase,
JAK/STAT), which promote the activation of early growth re-
sponse genes in hematopoietic cells [7, 10, 16–21, 39, 40].
Fig. 5. Erythropoietin (EPO)-induced intracellular inositol 1,4,5-
triphosphate (IP3) production. Mesangial cells with and without (E)
pretreatment with tyrosine kinase inhibitors, 100 mM genistein (F) for one
hour or 1 mM PP1 (a tyrosine kinase inhibitor; ) for 15 minutes, were
exposed to 20 U/ml EPO for various timed periods. IP3 was determined by
radioimmunoassay. Each datum point represents mean 6 SE for N 5 3
separate plates of mesangial cells.
Fig. 6. Erythropoietin (EPO)-induced intracellular Ca21 concentrations.
Mesangial cells with and without pretreatment with tyrosine kinase
inhibitors, 100 mM genistein for one hour or 1 mM PP1 (a tyrosine kinase
inhibitor) for 15 minutes, were exposed to 20 U/ml EPO for various timed
periods. Intracellular Ca21 was assessed by measuring the Indo-1 fluores-
cence of individual mesangial cells by confocal microscopy. Each datum
point represents mean 6 SE for N individual mesangial cells.
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Activation of all these same mitogenic factors by classic growth
factors and angiotensin II has been strongly implicated in the
clinical pathogenesis of maladaptive cellular growth in pathologic
disease processes (such as hypertension, cardiac failure, renal
failure) [27–29, 35]. Our study raises the concern that exogenous
EPO administration for the treatment of anemia may trigger
maladaptive growth in non-hematopoietic cells (such as mesangial
and vascular smooth muscle cells), potentially leading to the
acceleration of glomerulosclerosis, arteriosclerosis, and athero-
sclerosis. In rats, anemia retards the progression of proteinuria
and glomerulosclerosis after five-sixths nephrectomy [43]. How-
ever, glomerular injury and renal failure was accelerated when
these animals were treated with EPO.
Conclusions
Other investigators have shown that the EPO-induced increase
in intracellular Ca21 in vascular smooth muscle and hematopoi-
etic cells is due to extracellular Ca21 influx via a voltage-
independent Ca21 conductance. Our studies provide a candidate
pathway involving: (1) EPO binding to EPO receptors, which
leads to tyrosine phosphorylation of the -g1 isoenzyme of PLC
and membrane translocation of PLC-g1, where it forms a complex
with the EPO receptor itself. (2) PLC-g1-mediated hydrolysis of
PIP2 increases intracellular IP3. (3) Stimulation of Ca
21-activated
1 pS Ca21 channels is initially triggered by intracellular Ca21
release from IP3-dependent stores and is sustained by extracellu-
lar Ca21 entry via the channel itself (Fig. 7). Mene and associates
[30] have shown that the release of intracellular Ca21 stores on
extracellular Ca21 entry, promote voltage-independent Ca21 en-
try in human glomerular mesangial cells. They proposed that “the
InsP3 sensitive Ca21 pool may serve as a trigger for a sustained
response, thus initiating a cascade amplification signaling mecha-
nism.” Our results provide a potential mechanism for the common
hypertensive complications associated with the therapeutic ad-
ministration of EPO.
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